![](https://www.diabetesnews.com/wp-content/uploads/2015/02/80886684_a6190021-insulin_molecule-spl-1-150x150.jpg)
News came early in the year about Sanofi’s new basal insulin called Toujeo, which is a higher concentration than the long-established Lantus.
News came early in the year about Sanofi’s new basal insulin called Toujeo, which is a higher concentration than the long-established Lantus.